login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
IO BIOTECH INC (IOBT) Stock News
USA
- NASDAQ:IOBT -
US4497781090
-
Common Stock
1.02
USD
+0.2 (+24.36%)
Last: 10/21/2025, 8:23:40 PM
0.9399
USD
-0.08 (-7.85%)
After Hours:
10/21/2025, 8:23:40 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IOBT Latest News, Press Relases and Analysis
All
Press Releases
12 days ago - By: Chartmill
- Mentions:
SLE
USNA
VNRX
APM
...
The market is filled with gapping stocks in Friday's session.
2 days ago - By: Benzinga
- Mentions:
XRTX
REPL
AZTR
HSDT
...
12 Health Care Stocks Moving In Monday's Pre-Market Session
2 days ago - By: IO Biotech
IO Biotech Presents Phase 3 Results for Cylembio® plus KEYTRUDA® (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025
20 days ago - By: Benzinga
- Mentions:
BOLT
SCLX
TSHA
RVPH
...
12 Health Care Stocks Moving In Thursday's Intraday Session
22 days ago - By: Stocktwits
- Mentions:
MRK
IO Biotech Stock Plunges After FDA Recommends Another Trial For Investigational Cancer Vaccine
23 days ago - By: IO Biotech
IO Biotech Provides Update Following Pre-BLA Meeting with FDA
a month ago - By: IO Biotech
IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025
2 months ago - By: IO Biotech
IO Biotech Announces Participation in Upcoming Investor Conferences
2 months ago - By: Zacks Investment Research
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's What You Should Know
2 months ago - By: Yahoo Finance
H.C. Wainwright Reiterates Buy Rating on IO Biotech, Keeps PT at $14
2 months ago - By: The Motley Fool
Io Biotech Posts Wider Loss in Q2
2 months ago - By: IO Biotech
IO Biotech Reports Second Quarter 2025 Financial Results and Provides Business Highlights
2 months ago - By: Stocktwits
- Mentions:
MRK
IO Biotech Stock Slumps After Trial Of Cancer Therapy Plus Keytruda Misses Study Goal: Retail Sees Shares Rise 10x
Please enable JavaScript to continue using this application.